Bartholomeus J Van Steen

Title: Bartholomeus J Van Steen: Innovator in Pharmaceutical Chemistry

Introduction

Bartholomeus J Van Steen is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that target specific receptors in the human body.

Latest Patents

Van Steen holds a patent for "Hydronopol derivatives as agonists on human ORL1 receptors." This invention pertains to a group of hydronopol derivatives that act as agonists on human ORL1 (nociceptin) receptors. The patent also covers the preparation of these compounds, pharmaceutical compositions containing a pharmacologically active amount of at least one of these novel hydronopol derivatives, and their use in treating disorders associated with ORL1 receptors.

Career Highlights

Bartholomeus J Van Steen is currently associated with Solvay Pharmaceuticals GmbH, where he continues to advance his research and development efforts. His work focuses on creating innovative solutions that can improve patient outcomes through targeted therapies.

Collaborations

Throughout his career, Van Steen has collaborated with several esteemed colleagues, including Matthias Mentzel and Dania B Reiche. These collaborations have fostered a productive environment for innovation and discovery in pharmaceutical research.

Conclusion

Bartholomeus J Van Steen exemplifies the spirit of innovation in the pharmaceutical industry through his groundbreaking work on hydronopol derivatives. His contributions are paving the way for new treatments that could significantly impact healthcare.